News
Hosted on MSN3mon
Global study on depression identifies new genetic risk factorsScientists have identified new genetic risk factors for depression across all major global populations after a study involving five million participants, giving hope for new treatments.
A new international study reveals a possible connection between GLP1 receptor agonists—used in drugs like Ozempic—and ...
Feeling overwhelmed, anxious, or disconnected? The problem may not be you. It may be the world you’re living in. Here's why ...
Researchers have confirmed a genetic link to depression for the first time. Variations in two genes appeared more frequently in a population with major depressive disorder, according to a study ...
Depression makes deep inroads on biology to bring about the many symptoms of depression, from sleep disruption and an inability to experience pleasure to lack of motivation and feelings of guilt.
The innovative advance could shift treatment from response to prevention, and redefine how we think about this common maternal condition.
The authors found genetic associations between GLP1 receptor ... While the idea of GLP1 agonism induction of depression and SI is controversial with both negative and positive reporting, based ...
A genetic predisposition to neuroticism, insomnia, and depressive affect was associated with treatment-resistant depression development.
If you believe you or a loved one is experiencing depression, here's what mental health experts want you to know about symptoms and treatment.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results